Creating a new device to quickly sort rare blood cells one at a time
Official title: SBIR Fast Track: Development of a High-throughput Magnetic Cytometer for Single Cell Sorting
Funded at Microsensor Labs, LLC · NIH-10703514 · Data updated 2026-11-12
This study is working on a new device called MagiCyte™ that helps doctors quickly and accurately sort rare blood cells, which could lead to better treatments and tests for patients with conditions like cancer and those needing stem cell therapy.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Microsensor Labs, LLC NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project start | April 1, 2022 |
| Project end | August 31, 2025 |
| Funding year | 2023 |
| Award (this year) | $726,410 |
| NIH project number | 5R44GM145183-03 |
| Project ID | NIH-10703514 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals with conditions that involve rare blood cells, such as cancer patients or those requiring stem cell therapies.
✕Less likely to help
Patients with common blood disorders or those not requiring specialized cell sorting may not benefit from this research.
What this research studies
This project focuses on developing a high-throughput cell sorter called MagiCyte™ that can efficiently isolate and sort rare blood cells at a single-cell level. The device aims to overcome the limitations of current sorting techniques, which often result in cell loss and reduced viability. By utilizing a chip-based approach, the MagiCyte™ will allow for the rapid collection of intact and viable cells, which is crucial for applications in precision medicine, such as cancer treatment and stem cell research. Patients may benefit from improved diagnostic and therapeutic options as a result of this advanced technology.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments and diagnostics for conditions involving rare blood cells.
How similar studies have gone: Other research has shown promise in developing advanced cell sorting technologies, indicating a potential for success with this novel approach.
Where this research is happening
-
Microsensor Labs, LLC
Chicago, United States Active
Researchers
- Principal investigator: Liu, Peng Paul — Microsensor Labs, LLC
- Study coordinator: Liu, Peng Paul
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.